You are here

Agency Actions

FDA establishes a pathway to speed approval for similar tests
The practice adds to drug resistance in humans and the potential for “superbugs”
Agent treats certain chronic pulmonary infections in patients with cystic fibrosis
Braeburn, Indivior recommended by large margins
Inconsistent evidence prompts agency to re-evaluate link between soy products and cardiovascular health
MM-121 is a fully human monoclonal antibody designed to block tumor survival signals
Vaccination now recommended starting at age 50
Duchenne muscular dystrophy drug fared poorly in trials
BioMarin Pharmaceutical is developing valoctocogene roxaparvovec